March 7 (Reuters) - The U.S. Food and Drug Administration has granted accelerated approval for the expanded use of BeiGene's combination drug to treat certain patients with a type of blood cancer, the health regulator said on Thursday. (Reporting by Sriparna Roy, Sneha S K and Mariam Sunny in Bengaluru; Editing by Devika Syamnath and Shounak Dasgupta)
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
The $50 million purchase could turn into Nvidia's biggest investment.
These proven wealth builders could be exactly what you're searching for right now.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
$10,000 to each of these companies could deliver major returns over the next decade.
In an expression of disapproval on social media, prominent real estate investor Grant Cardone scrutinized President Joe Biden's proposed hike in capital gains tax in a recent X post. "Biden proposes 44.6% capital gains tax, from current 19%," Cardone posted. "Can't even come up with his own ideas taking a page out of Trudeau playbook who raised Canada to 66%." Cardone then invoked historical political outcomes, writing, "And he ignored how that played out for the last guy who tried it — the enti
There are benefits to investing in stocks that have reasonable multiples and aren't as dependent on future earnings growth to justify their valuations.
The JPMorgan Nasdaq Equity Premium Income ETF offers a compelling blend of income and upside to my portfolio.
Jamie Dimon and Jerome Powell are taking the European viewpoint on soaring debt levels in the U.S.